Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis, molecular modeling, and dopamine receptor affinity of tetrahydroisoquinoline derivatives

Thesis/Dissertation ·
OSTI ID:7266868

A series of 1-phenyl, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines have been prepared as ring contracted analogs of the prototypical D{sub 1} dopamine receptor antagonist, SCH23390 ((R+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine). Two 4-phenyl-1,2,3,4-tetrahydroisoquinolines not prepared by the author were also evaluated. The affinity and selectivity of these tetrahydroisoquinolines for D{sub 1} receptors was determined by three biochemical endpoints in membrane homogenates prepared from rat corpus striatum: the potency to compete for ({sup 3}H)-SCH23390 binding sites; the potency to compete for ({sup 3}H)-spiperone binding sites; and effects on dopamine-stimulated adenylate cyclase. Competitive binding measurements at D{sub 1} sites showed SCH23390 to possess the highest affinity, followed in order of decreasing potency by the 1-phenyl, 1-benzyl, and 4-phenylisoquinolines. Conformational studies on these tetrahydroisoquinolines using molecular mechanics (MM2-85), single crystal X-ray analysis and high-field NMR on both the free-base and ammonium forms of each compounds were carried out.

Research Organization:
North Carolina Univ., Chapel Hill, NC (USA)
OSTI ID:
7266868
Country of Publication:
United States
Language:
English